Common variants in genes that encode proteins of the alternative complement pathway, a part of the immune system, may raise…
Articles by Margarida Maia, PhD
An 18-month fixed-schedule maintenance regimen of rituximab is better at keeping ANCA-associated vasculitis (AAV) in remission for up to…
A Phase 2 clinical trial testing Q32 Bio’s ADX-097 in people with ANCA-associated vasculitis (AAV) will be the…
Granulomatosis with polyangiitis (GPA) is the most common type of ANCA-associated vasculitis (AAV) in Italy and is linked…
People with ANCA-associated vasculitis (AAV) may present different lung involvement patterns depending on the type of disease and self-reactive…
A low dose of intravenous or into-the-vein methylprednisolone, a corticosteroid, is as safe and effective as a high dose at…
A protein fragment called Ba that’s produced when the alternative complement pathway is activated is found at high levels in…
AstraZeneca’s Fasenra (benralizumab) — approved for a rare type of asthma — does no worse than Nucala (mepolizumab)…
Microscopic polyangiitis (MPA) was the most common type of ANCA-associated vasculitis (AAV) among girls and Hispanic children in a…
An approach that removes specific antibodies from a person’s blood is better than a standard, more general blood-cleaning procedure called…